<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://fullstackmed.com/article/ced0a79e-9e6f-42a5-a869-c9ac6ad84a95</loc><news:news><news:publication><news:name>Full Stack Medicine</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T02:46:21.703Z</news:publication_date><news:title>Review: Orforglipron Tolerability Is Not Superior to Injectable Peptides</news:title></news:news></url>
  <url><loc>https://fullstackmed.com/article/6c483c1f-8121-4e3f-97e6-495fd1f37fbd</loc><news:news><news:publication><news:name>Full Stack Medicine</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T12:46:21.676Z</news:publication_date><news:title>Tirzepatide for Adolescent Obesity: Findings From the SURMOUNT-ADOLESCENTS Randomized Clinical Trial</news:title></news:news></url>
  <url><loc>https://fullstackmed.com/article/426c8ea5-ea12-4490-a451-09647a145bcd</loc><news:news><news:publication><news:name>Full Stack Medicine</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T02:46:33.411Z</news:publication_date><news:title>Review: Cardiovascular Protection With Pneumococcal Vaccines Remains Unproven</news:title></news:news></url>
  <url><loc>https://fullstackmed.com/article/3eec06f2-adc2-40cb-999c-7d68e7403ee9</loc><news:news><news:publication><news:name>Full Stack Medicine</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T22:46:32.997Z</news:publication_date><news:title>Premature Ovarian Insufficiency in Primary Care</news:title></news:news></url>
  <url><loc>https://fullstackmed.com/article/3d36718b-144f-40d5-a2fe-edb18d2dca6f</loc><news:news><news:publication><news:name>Full Stack Medicine</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T12:46:33.241Z</news:publication_date><news:title>Teneligliptin (Investigational) Add-On Therapy to Empagliflozin and Metformin in Type 2 Diabetes</news:title></news:news></url>
  <url><loc>https://fullstackmed.com/article/b56f5975-6ea1-45eb-ab84-5adbc9375f9b</loc><news:news><news:publication><news:name>Full Stack Medicine</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T12:46:33.107Z</news:publication_date><news:title>Clinical Management and Practice Variations in Wearable-Detected Atrial Fibrillation</news:title></news:news></url>
</urlset>